STOCKNO.DE
Institutional ownership intelligence
Schedule 13G/A

FEED Schedule 13G/A filing by Bank of America

Bank of America reported beneficial ownership of 14 shares, representing 0% of ENvue Medical, Inc. in this filing.

FiledMar 6, 2026
Ownership dateFeb 27, 2026
Reported shares14
Reported ownership0%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 0
Shared voting power 14
Sole dispositive power 0
Shared dispositive power 14
Compared with the prior filing

How the reported position changed

This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for FEED. A change between filings does not by itself establish when shares were bought or sold.

Previous filingFeb 6, 2026
Reported share change-234,221
Ownership percentage change-21.5 pts
Previous filingThis filing
Reported shares234.2K14
Reported ownership21.5%0%
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$2.01as of Mar 6, 2026
Latest tracked price$0.38as of Aug 7, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Bank of America
CIK
CIK0000070858
Accession
0000070858-26-000192
Form
Schedule 13G/A
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.